Learn more

MOGAM INST FOR BIOMEDICAL RES

Overview
  • Total Patents
    16
  • GoodIP Patent Rank
    109,389
  • Filing trend
    ⇩ 100.0%
About

MOGAM INST FOR BIOMEDICAL RES has a total of 16 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2012. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are GLYCONEX INC, EMERGENT BIOSOLUTIONS CANADA INC and AEBI LTD.

Patent filings in countries

World map showing MOGAM INST FOR BIOMEDICAL RESs patent filings in countries
# Country Total Patents
#1 Republic of Korea 8
#2 WIPO (World Intellectual Property Organization) 4
#3 China 3
#4 Canada 1

Patent filings per year

Chart showing MOGAM INST FOR BIOMEDICAL RESs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Park Young Seoub 8
#2 Park Jae Chan 8
#3 Kim Dong Sik 5
#4 Lim Hyung Kwon 5
#5 Lee Mi Jung 5
#6 Song Eun Jung 4
#7 Lim Hyung-Kwon 3
#8 Kim Ki Su 3
#9 Kim Kisu 3
#10 Kim Dong-Sik 3

Latest patents

Publication Filing date Title
KR20170073574A PHARMACEUTICAL COMPOSITION FOR PREVENTING cccDNA FORMATION OF HEPATITIS B VIRUS
WO2017010845A1 Composition for preventing or treating staphylococcal infectious diseases
KR20170049831A Novel Antibody Against Glypican 3, and Pharmaceuitical Composition Comprising the Same
KR20170036505A Novel Antibody Binding to TFPI, and Composition Comprising the Same
KR20170036503A Novel Antibody Binding to Mesothelin(MSLN), and Composition Comprising the Same
KR20170024963A Composition for improving condition and function of cells comprising cathepsin k as active ingredient
KR20170011863A PHARMACEUTICAL COMPOSITION FOR PREVENTING cccDNA FORMATION OF HEPATITIS B VIRUS
KR20160103767A Novel Antibody Binding to TFPI, and Composition Comprising the Same